Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Shetty

Showing results (761-770 of 780) with videos related to

Pageof 78
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 monthsAvinash K Shetty, Hoosen M Coovadia, Mark M Mirochnick, et al.
Aging and Disease|June 4, 2020
COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?Sankha Shubhra Chakrabarti, Upinder Kaur, Anindita Banerjee, et al.
Frontiers in Immunology|January 22, 2026
Host-membrane lipid composition controls <i>Cryptococcus neoformans</i> cellular targetsAswathi I Ramesh, Sumukha Hegde, Aarsh Mahendra Dabhi, et al.
Journal of Clinical Medicine|January 11, 2022
Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 TrialEsther Natalie Oliva, Uwe Platzbecker, Guillermo Garcia-Manero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 23, 2022
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS StudyUwe Platzbecker, Katharina S Götze, Philipp Kiewe, et al.
Molecular Neurobiology|July 4, 2024
Potential Mechanisms Underlying COVID-19-Mediated Central and Peripheral Demyelination: Roles of the RAAS and ADAM-17Kellysson Bruno Oliveira, Fernanda Maria Araujo de Souza, Letícia Barros Maurício de Sá, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|August 30, 2005
Ultra-wide bore 900 MHz high-resolution NMR at the National High Magnetic Field LaboratoryR Fu, W W Brey, K Shetty, et al.
Oncogene|June 5, 2007
Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activationK Kitisin, N Ganesan, Y Tang, et al.
European Journal of Haematology|April 24, 2023
Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspaterceptMaria Domenica Cappellini, Ali T Taher, Antonio Piga, et al.
Journal of Extracellular Vesicles|December 12, 2024
A perspective from the National Eye Institute Extracellular Vesicle Workshop: Gaps, needs, and opportunities for studies of extracellular vesicles in vision researchSun Young Lee, Mikael Klingeborn, Jeff W M Bulte, et al.
Pageof 78

Showing results (761-770 of 780) with videos related to

Sort By:
Pageof 78
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 monthsAvinash K Shetty, Hoosen M Coovadia, Mark M Mirochnick, et al.
Aging and Disease|June 4, 2020
COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?Sankha Shubhra Chakrabarti, Upinder Kaur, Anindita Banerjee, et al.
Frontiers in Immunology|January 22, 2026
Host-membrane lipid composition controls <i>Cryptococcus neoformans</i> cellular targetsAswathi I Ramesh, Sumukha Hegde, Aarsh Mahendra Dabhi, et al.
Journal of Clinical Medicine|January 11, 2022
Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 TrialEsther Natalie Oliva, Uwe Platzbecker, Guillermo Garcia-Manero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 23, 2022
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS StudyUwe Platzbecker, Katharina S Götze, Philipp Kiewe, et al.
Molecular Neurobiology|July 4, 2024
Potential Mechanisms Underlying COVID-19-Mediated Central and Peripheral Demyelination: Roles of the RAAS and ADAM-17Kellysson Bruno Oliveira, Fernanda Maria Araujo de Souza, Letícia Barros Maurício de Sá, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|August 30, 2005
Ultra-wide bore 900 MHz high-resolution NMR at the National High Magnetic Field LaboratoryR Fu, W W Brey, K Shetty, et al.
Oncogene|June 5, 2007
Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activationK Kitisin, N Ganesan, Y Tang, et al.
European Journal of Haematology|April 24, 2023
Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspaterceptMaria Domenica Cappellini, Ali T Taher, Antonio Piga, et al.
Journal of Extracellular Vesicles|December 12, 2024
A perspective from the National Eye Institute Extracellular Vesicle Workshop: Gaps, needs, and opportunities for studies of extracellular vesicles in vision researchSun Young Lee, Mikael Klingeborn, Jeff W M Bulte, et al.
Pageof 78